Last updated: April 24, 2026

Application No. 19/391,715

Untitled Application

Unknown

Filed

1600

Examiner

SIMMONS, CHRIS E

Art Unit

1622

Tech Center

Cardiff Oncology, Inc.

Assignee

Cardiff Oncology Inc.

OA Round

1 (Non-Final)

This examiner grants 34% of cases after interview

— +19.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 666 resolved cases, 2023–2026

Examiner Intelligence

SIMMONS, CHRIS E View full profile →

Grants only 34% of cases

Career Allow Rate

230 granted / 666 resolved

-25.5% vs TC avg

Strong +19% interview lift

Without

With

+19.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 10m

Avg Prosecution

46 currently pending

Career history

712

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

46.2%

+6.2% vs TC avg

§102

14.3%

-25.7% vs TC avg

§112

23.8%

-16.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 666 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

16/613,480

Patent 12582635

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS

2y 5m to grant Granted Mar 24, 2026

17/913,498

Patent 12534435

NOVEL LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF

2y 5m to grant Granted Jan 27, 2026

18/782,646

Patent 12521400

ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS

2y 5m to grant Granted Jan 13, 2026

18/725,257

Patent 12514845

IONIC-LIQUID-BASED FORMULATIONS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES

2y 5m to grant Granted Jan 06, 2026

16/614,335

Patent 12502362

INHIBITORS OF NUCLEOTIDYLTRANSFERASE SUPERFAMILY ENZYMES AS ANTIBIOTICS

2y 5m to grant Granted Dec 23, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

34%

Grant Probability

54%

With Interview (+19.4%)

3y 10m

Median Time to Grant

Low

PTA Risk

Based on 666 resolved cases by this examiner. Grant probability derived from career allow rate.